Beckwith-Wiedemann syndrome and Wilms' tumour

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

Patients with rare overgrowth disorders, such as Beck-Wiedemann syndrome and Simpson-Golabi-Behmel syndrome, are predisposed to embryonal tumours, including Wilms' tumour of the kidney. Therefore, these disorders offer a link between hyperplastic growth and cancer. Genetic lesions at chromosome 11p15 have been associated with Beck-Wiedemann syndrome and Wilms' tumour for several years and the presence of the gene encoding insulin-like growth factor-II (IGF-II) in this region has given rise to much speculation over the involvement of this factor in these growth defects. This speculation was heightened by genetic evidence for the involvement of genomic imprinting in Beck-Wiedemann syndrome and Wilms' tumour, combined with the discovery that the IGF-II gene is imprinted. Although there is a wealth of evidence linking the IGF signalling pathway with overgrowth and cancer, recent progress in the study of 11p15 and developments in our understanding of the mechanism of genomic imprinting indicate that additional imprinted genes located in this region also contribute to these growth disorders.
LanguageEnglish
Pages157-168
Number of pages12
JournalMolecular Human Reproduction
Volume3
Issue number1
DOIs
StatusPublished - 1 Feb 1997

Fingerprint

Beckwith-Wiedemann Syndrome
Wilms Tumor
Genomic Imprinting
Insulin-Like Growth Factor II
Growth Disorders
Genes
Neoplasms
Intercellular Signaling Peptides and Proteins
Chromosomes
Kidney
Growth

Cite this

Beckwith-Wiedemann syndrome and Wilms' tumour. / Ward, Andrew.

In: Molecular Human Reproduction, Vol. 3, No. 1, 01.02.1997, p. 157-168.

Research output: Contribution to journalReview article

@article{4a8553abc1934d088aaa48873fdbe792,
title = "Beckwith-Wiedemann syndrome and Wilms' tumour",
abstract = "Patients with rare overgrowth disorders, such as Beck-Wiedemann syndrome and Simpson-Golabi-Behmel syndrome, are predisposed to embryonal tumours, including Wilms' tumour of the kidney. Therefore, these disorders offer a link between hyperplastic growth and cancer. Genetic lesions at chromosome 11p15 have been associated with Beck-Wiedemann syndrome and Wilms' tumour for several years and the presence of the gene encoding insulin-like growth factor-II (IGF-II) in this region has given rise to much speculation over the involvement of this factor in these growth defects. This speculation was heightened by genetic evidence for the involvement of genomic imprinting in Beck-Wiedemann syndrome and Wilms' tumour, combined with the discovery that the IGF-II gene is imprinted. Although there is a wealth of evidence linking the IGF signalling pathway with overgrowth and cancer, recent progress in the study of 11p15 and developments in our understanding of the mechanism of genomic imprinting indicate that additional imprinted genes located in this region also contribute to these growth disorders.",
author = "Andrew Ward",
year = "1997",
month = "2",
day = "1",
doi = "10.1093/molehr/3.2.157",
language = "English",
volume = "3",
pages = "157--168",
journal = "Molecular Human Reproduction",
issn = "1360-9947",
publisher = "Oxford Univerity Press",
number = "1",

}

TY - JOUR

T1 - Beckwith-Wiedemann syndrome and Wilms' tumour

AU - Ward, Andrew

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Patients with rare overgrowth disorders, such as Beck-Wiedemann syndrome and Simpson-Golabi-Behmel syndrome, are predisposed to embryonal tumours, including Wilms' tumour of the kidney. Therefore, these disorders offer a link between hyperplastic growth and cancer. Genetic lesions at chromosome 11p15 have been associated with Beck-Wiedemann syndrome and Wilms' tumour for several years and the presence of the gene encoding insulin-like growth factor-II (IGF-II) in this region has given rise to much speculation over the involvement of this factor in these growth defects. This speculation was heightened by genetic evidence for the involvement of genomic imprinting in Beck-Wiedemann syndrome and Wilms' tumour, combined with the discovery that the IGF-II gene is imprinted. Although there is a wealth of evidence linking the IGF signalling pathway with overgrowth and cancer, recent progress in the study of 11p15 and developments in our understanding of the mechanism of genomic imprinting indicate that additional imprinted genes located in this region also contribute to these growth disorders.

AB - Patients with rare overgrowth disorders, such as Beck-Wiedemann syndrome and Simpson-Golabi-Behmel syndrome, are predisposed to embryonal tumours, including Wilms' tumour of the kidney. Therefore, these disorders offer a link between hyperplastic growth and cancer. Genetic lesions at chromosome 11p15 have been associated with Beck-Wiedemann syndrome and Wilms' tumour for several years and the presence of the gene encoding insulin-like growth factor-II (IGF-II) in this region has given rise to much speculation over the involvement of this factor in these growth defects. This speculation was heightened by genetic evidence for the involvement of genomic imprinting in Beck-Wiedemann syndrome and Wilms' tumour, combined with the discovery that the IGF-II gene is imprinted. Although there is a wealth of evidence linking the IGF signalling pathway with overgrowth and cancer, recent progress in the study of 11p15 and developments in our understanding of the mechanism of genomic imprinting indicate that additional imprinted genes located in this region also contribute to these growth disorders.

U2 - 10.1093/molehr/3.2.157

DO - 10.1093/molehr/3.2.157

M3 - Review article

VL - 3

SP - 157

EP - 168

JO - Molecular Human Reproduction

T2 - Molecular Human Reproduction

JF - Molecular Human Reproduction

SN - 1360-9947

IS - 1

ER -